Article info
PDFReview
Molecular diagnosis in non-small-cell lung cancer: expert opinion on ALK and ROS1 testing
- Correspondence to Dr Esther Conde, CIBERONC, 28050 Madrid, Spain; econde{at}hmhospitales.com
Citation
Molecular diagnosis in non-small-cell lung cancer: expert opinion on ALK and ROS1 testing
Publication history
- Received February 15, 2021
- Revised March 22, 2021
- Accepted March 24, 2021
- First published April 19, 2021.
Online issue publication
February 17, 2022
Article Versions
- Previous version (17 February 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.